Previous close | 13.09 |
Open | 12.98 |
Bid | 12.98 x 200 |
Ask | 13.03 x 100 |
Day's range | 12.90 - 13.16 |
52-week range | 9.57 - 21.60 |
Volume | |
Avg. volume | 350,580 |
Market cap | 486.286M |
Beta (5Y monthly) | 1.05 |
PE ratio (TTM) | N/A |
EPS (TTM) | -4.12 |
Earnings date | 07 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 18.47 |
13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities.
LEWISVILLE, Texas, April 23, 2024--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its first quarter 2024 financial results on Tuesday, May 7, 2024 before market open. The Company will host a conference call and webcast to review results at 8:30 a.m. ET the same day.
LEWISVILLE, Texas, April 16, 2024--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Andres Cedron has joined the company as Chief Legal Officer.